Tumor Immunology Training Program
The National Cancer Institute T32-funded Tumor Immunology Training Program has the goal to train the next generation of leaders in translational immunology who can bridge bench work to clinical practice that leads to novel strategies to combat cancer. It aims to train a total of 2 predoctoral and 8 postdoctoral fellows, each for 3 years. Training is under 16 outstanding faculty members comprising of a mix of basic and clinical investigators who have a history of working together to solve barriers to immunity against cancer.
There are three areas of focus:
1. innate immunity, inflammation and cancer,
2. adaptive immunity,
3. immunotherapeutic strategies in cancer patients, integrate the research efforts of the faculty, which provide a multidisciplinary environment that benefit trainees for transition from mouse to man research.
To take advantage of this setting, the Ph.D. Program in Cancer Biology, in its 15th year, has a curriculum that minimizes coursework and emphasizes laboratory research on a project co-mentored by a basic scientist and a physician scientist. Postdoctoral candidates also design a co-mentored project that addresses a critical issue in cancer immunity. Trainees working side by side with clinical mentors and their medical staff in the hospital setting will gain the necessary skills to conduct research in the interface of basic science and medicine.
To view the open position on the Tumor Immunotherapy Training Award and all other available positions, please click this link and search for the position titled Post Doc Fellow.